Teleflex Inc (TFX)
239.18
-0.36
(-0.15%)
USD |
NYSE |
Oct 04, 16:00
239.20
+0.02
(+0.01%)
After-Hours: 20:00
Teleflex SG&A Expense (Annual): 929.87M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 929.87M |
December 31, 2022 | 863.75M |
December 31, 2021 | 860.08M |
December 31, 2020 | 743.57M |
December 31, 2019 | 851.77M |
December 31, 2018 | 797.06M |
December 31, 2017 | 699.96M |
December 31, 2016 | 563.31M |
December 31, 2015 | 568.98M |
December 31, 2014 | 578.66M |
December 31, 2013 | 502.19M |
December 31, 2012 | 454.49M |
December 31, 2011 | 423.91M |
December 31, 2010 | 403.64M |
December 31, 2009 | 454.23M |
December 31, 2008 | 562.64M |
December 31, 2007 | 445.25M |
December 31, 2006 | 374.96M |
December 31, 2005 | 333.83M |
December 31, 2004 | 487.10M |
Date | Value |
---|---|
December 31, 2003 | 392.96M |
December 31, 2002 | 336.85M |
December 31, 2001 | 347.13M |
December 31, 2000 | 311.28M |
December 31, 1999 | 284.70M |
December 31, 1998 | 266.10M |
December 31, 1997 | 230.20M |
December 31, 1996 | 190.30M |
December 31, 1995 | 192.40M |
December 31, 1994 | 173.90M |
December 31, 1993 | 141.00M |
December 31, 1992 | 124.20M |
December 31, 1991 | 93.70M |
December 31, 1990 | 84.80M |
December 31, 1989 | 63.90M |
December 31, 1988 | 59.10M |
December 31, 1987 | 49.60M |
December 31, 1986 | 39.80M |
December 31, 1985 | 31.70M |
December 31, 1984 | 28.50M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
743.57M
Minimum
2020
929.87M
Maximum
2023
849.81M
Average
860.08M
Median
2021
SG&A Expense (Annual) Benchmarks
Haemonetics Corp | 431.78M |
Abbott Laboratories | 10.95B |
Boston Scientific Corp | 5.19B |
Insulet Corp | 734.90M |
908 Devices Inc | 46.18M |